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Shaping the Future
Collaborative Models 
for Healthcare 
Innovation
Professor David Mullins
Director External & International 
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Warwick 
Innovation within Healthcare System
 NHS National Institute for Healthcare Research
– Biomedical Research Centres , Translational Research Partnerships
– Clinical Research Facilities, Clinical Research Networks etc. 
 Charities – BHF, Cancer Research UK, Wellcome Trust etc.
 Research Councils – MRC and BBSRC
 Companies - Pharmaceutical etc. 
Innovation into Healthcare System
 With Universities
 With multiple organisations
 To access ‘big facilities’
 Innovations from external disciplines - IDH
 Innovations from SMEs
 To exploit new areas of opportunity
 Education and training
 The role of impact 
Research Landscape 
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RCUK (MRC etc.)
0-50% Industry Funding
10-15 years to 
Implementation
Collaborative R&D  
Driven
Innovate UK, Horizon 2020, 
Catapult
50% Industry Funding
5-10 Years to 
Implementation
Healthcare and 
Industry Driven
50-100% Industry Funding
0-5 Years to 
Implementation
Academic Led
Research Fellow
EngD/PhD
Project Manager Led
Project Engineer
Research Fellow
Technology 
Readiness 
Level
Activity
Staffing
Basic 
Technology 
Research 
Feasibility
Study
Technology 
Development
Technology
Demonstration
System
Development
System Test
Academic Health Science Networks
IDH hosts the Digital 
Innovation Service for the 
WM AHSN
And runs the West 
Midlands Health 
Informatics Network 
(WIN)
With Universities   
 UK Research Partnership Investment Fund
 RM 218M - GSK Carbon Neutral Lab for Sustainable 
Chemistry (GSK and Nottingham)
 RM 308M - Institute of Cancer Research (Manchester, 
Christie Hospital and Cancer Research UK)
 RM 545M - Centre for Children’s Rare Disease Research 
(UCL, Great Ormond Street Hospital)
 RM 205M - Institute of Health Sciences (QU Belfast, Altalia
Philanthropies and Wellcome/Wolfson)
With Multiple Organisations 
 The Francis Crick Institute 
 RM 4.1bn. - opens  2016, 1250 co-located scientists
http://crick.ac.uk
The Francis Crick Institute 
 Biomedical Discovery Institute 
– MRC, Cancer Research UK, Wellcome Trust, UCL, Imperial College, Kings 
College London  
 Why disease develops? – treat, diagnose, prevent major 
diseases
 Researchers, disciplines, academic institutions, healthcare 
organisations and business e.g.
– Open Science Collaboration with GSK
 Highest quality science, young and emerging talent
To Access ‘Big Facilities’ 
 Research Complex @ Harwell 
 RM 170 M Labs and Shared Facilities for Structure of 
Matter
 Adjacent to DIAMOND, ISIS and CLF
 Imaging (live biological cells), Structural Molecular Biology 
(proteins), Dynamic Processes (DNA molecules) 
 Long term residencies
From external disciplines
 Institute of Digital Healthcare  
 To improve people’s health and wellbeing through the use 
of innovative digital technologies 
 To deliver excellent research, training and implementation
 To achieve translational impact in society 
 45 members - Interdisciplinary profile 
Patient & population data: Deriving new knowledge & 
measure performance
• Big Data analysis
• Primary care data, e.g. Electronic 
Healthcare Records, THIN 
• Hospital data, e.g. PICS 
• Collaboration with the University 
Hospital Birmingham  NHS Trust
• Clinical Research Informatics
• Clinical Trial Management Systems 
• EU TRANSFoRm FP7 Programme
• WM AHSN
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Ideal Model ROC area: 0.810 Pragmatic model ROC area: 0.802
Test Model ROC area: 0.784 Reference
Brain Cancer Database for Children
Spectroscopic imaging in clinical decisions
Thalamic diffuse 
astrocytoma
mIns – low grade Cho – high grade
A.C.Peet, T.N.Arvanitis, M.O.Leach, A.. D Waldman, Nat. Rev. Clin. Oncol. 2012;(9):700-711 
Cybersecurity of Medical Devices
 In 2012, Jay Radcliffe, an Idaho-based hacker and 
Type 1 diabetic, demonstrated that hackers could 
manipulate his insulin pump.  A lethal dose of 45 
days insulin could be administered in a single bolus 
to the patient resulting in hypoglycemia. 
 Kevin Fu and James Blum reported Conficker
malware on 104 devices at the James A. Haley 
Veterans’ Hospital in Tampa. Affected devices 
included X-ray machine and mammography.
 Evaluation in the Clinical Setting / Involvement of 
Clinical Staff in the Technology Design Process
CASE STUDY:
A Chest Wall Motion Assessment System based on games technology
KTP with Heart of England Foundation Trust, NHS
Clinical Evaluation 
Visualisation, Modelling & Simulation 
Designing Patient-Specific Optimal Surgery : A Bi-Ventricular Modelling of the 
Human Heart – Collaboration with University Hospital Coventry and 
Warwickshire NHS Foundation Trust 
• To study the mechanical characteristics of normal LV and LV with aneurysm
• Investigate the effects of different types of suturing techniques and its orientations 
on the mechanical characteristics of the diseased LV 
Benefits:
• Avoiding unnecessary surgery & related rehabilitation procedure 
• Time & Cost  reduction
Normal Normal Normal
Aneurysm Aneurysm Aneurysm Surgical Simulation
Optimal 
surgery
Patient Specific Medical Models
Used for:
- Surgery rehearsal
- Surgical Training
- Communicate to patients
- In-theatre visual references
- Jigs to shape off-the-shelf 
implants
‘The Mechanics of Man’ – Royal Collection,  
Holyrood, 2013
Specific Examples:
- Orthopaedic surgical rehearsal
- Forensics
Product Development
Product Development
- Working with UHCW to develop innovations for the NHS
- Combination of 3DP and clinical expertise  leading to real exploitable 
innovation 
Realistic Medical Modelling
- Collaborating with EU Consortium to develop 
patient specific multi-scale model of the lung  
as a new way of characterising asthma and 
COPD 
Hospital Modelling
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Methodology Developed: Pathway Variation Analysis (PVA)
Implementation Results at the University Hospitals Coventry and Warwickshire
Problem: Acute stroke patients diverting from stroke pathway in ED resulted in hospital unable to meet DoH performance   
target (80% of stroke patients spend >90% of hospital stay in stroke unit)
Results: PVA-driven results leading UHCW to meet target first time since target mandated.
Potential predicted Impact of FND***
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• UHCW Quality 
Account 2009/10
** Sample comprised of
acute stroke patients  
treated at UHCW.
*** Predicted impact of 
focal neurological 
deficit (FND) patients 
on stroke care 
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Q1 73.00
2009/10* 62.20
2008/09* 56.76
Suggestion    Re-designed sequence of clinical decision-making by having ED clinicians concentrate their clinical assessment on rapidly detecting  
presentations of  focal neurological deficits (FND) which led to improved diagnostic accuracy of stroke referral from ED to stroke team.
To manage the patient flow due to increased number of stroke patients correctly identified in ED:                            
Suggestion    Increase hyper-acute stroke unit capacity from 4 beds to 6 beds to manage increased patient flow & eliminate bottlenecks
Suggestion               Balance bed capacity to manage patient flow variation by relocating entire hyper-acute stroke unit into the acute stroke ward
(1): Patient diverting 
from care pathway
(2): Balance stroke unit
bed capacity to
manage increased
incoming patient 
flow & variation
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Innovations from SMEs 
 Medilink UK 
 Stimulate growth and innovation
 West Midlands – 200+ member organisations – materials 
to components
 ‘Selling’ to NHS 
– Dyecor – ‘Thermcool’ transport drugs and blood products
– 365 Healthcare – neck drape for complex surgical procedures
– Quadraline – specialised cleaning fluids (ex motor industry) 
Innovations from SMEs 
R&D
Innovation 
Programme 200pa
300 members 
Industry Networks & Guilds
600pa Technology Awareness 
Demonstrations
15,000 WMG SME contacts
50,000 Members of partners organisations 
389,000 in West Midlands, 4.9 million SMEs in the UK
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Demonstration: Workshops, sandpits, ideation…
Finance: inc. Angel networks
Skills: Interns, PgA, WMG academy
Mentoring & Support Intensive tech-led projects
Incubation: Physical and Virtual 
Support to develop technology
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Intensive 
Projects 100pa
Understand & Access R&D funding
Supporting companies to bid
TSB, NESTA, H2020…
Exploit new areas of opportunity 
 Cell Therapy Catapult
 Grow UK cell and gene therapy industry to enable health 
and wealth 
 RM 353M - cell and gene therapy manufacturing centre –
process and assay development labs
 Space for collaboration, R&D to make risk manageable
 To grow cluster of activity and enable inward investment
24
Education and Training
Medical Packaging Technology
Education and Training 
 MSc Healthcare Operational 
Management (Oct 2016) full-time 
& part-time
 Online Short and Professional 
Courses –NHS, industry and 
healthcare providers focus
• Advanced practitioner: Eating Behaviour (NHS 
staff e.g., dieticians; nurses)
• Health informatics 
• Clinical IT safety
 MRes(earch) – online in planning
• Digital Healthcare
• Health informatics 
• Obesity & Eating Behaviour
• Behaviour Change in Ehealth
Education and training
 Understanding Eating Disorders: For Teachers and Schools
“Early identification of disordered eating is essential. It predicts recovery rates and 
other important outcomes. Often teachers lack confidence in dealing with these 
issues in school.”
Course Aims
To inform teachers of up-to-date evidence about eating disorders and dispel 
any myths
• To help them feel empowered and spot early signs
• To give them confidence in approaching pupils
• To provide evidence-based information to pass on to parents/peers etc.
• To help them to consider important ways in which schools might help
Course Format and Delivery
The course is delivered using best practice e-learning via the University of 
Warwick e-learning portal. 
The role of Impact 
 Impact of research included for the first time
 “An effect on, change or benefit to the economy, society, culture, 
public policy or services, health, the environment or quality of life, 
beyond academia”
 Encouraging all faculty to consider and enable the impact of their 
research – leading to significant innovation in healthcare
Research Excellence 
Framework assessed the 
quality of research in all UK 
universities, in all 
disciplines. It was carried 
out by 36 expert panels, 
grouped into 4 main panels.
Main Panel A: Medical and life sciences
Main Panel B: Physical sciences and engineering
Main panel C: Social sciences
Main Panel D: Arts and humanities
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